$1.88
0.116.21%
At close: -
$1.88
0.000.00%
After Hours: 5:46 PM EDT
Standard BioTools reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Standard BioTools using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-10-30 | $-0.07 | $-0.09 | 22.2 % |
Q4 | 2022-02-17 | $-0.01 | $-0.28 | 96.4 % |
Q3 | 2021-11-08 | $-0.07 | $-0.22 | 68.2 % |
Q2 | 2021-08-05 | $-0.12 | $-0.20 | 40.0 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-10-30 | $44.97M | $41.00M | 9.68 % |
Q3 | 2022-11-08 | $25.65M | $26.50M | -3.22 % |
Q2 | 2022-08-08 | $18.78M | $26.50M | -29.1 % |
Q1 | 2022-05-05 | $26.50M | $25.60M | 3.53 % |
Standard BioTools (LAB) is scheduled to report earnings on February 26, 2025. The last reported earnings were for reported on October 30, 2024 for Q3.
The Actual EPS was $-0.07, which beat the estimate of $-0.09.
The Actual Revenue was $45M, which beat the estimate of $41M.
Browse earnings estimates, EPS, and revenue on all stocks.